Key Highlights
•
Researchers have identified a key protein, TIE2, as the critical link between two major cellular signaling pathways that drive the growth of cerebral cavernous malformations (CCMs), which are abnormal blood vessel clusters in the brain. This discovery suggests that drugs targeting the TIE2 receptor could be a promising new strategy to treat these lesions and prevent associated strokes and seizures.
Source →
•
The study found that blocking TIE2 signaling, either genetically or with drugs, almost completely stopped the formation of CCMs in mouse models, while blocking a different receptor (VEGFR2) had no effect. This pinpointing of TIE2 as the specific driver offers a more precise and potentially effective therapeutic target for a condition that currently lacks good drug treatments.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
